Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study

Lignende værker

• Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2–59 Months of Age, Spain
  af: Hernández, Sergi, et al.
  Udgivet: (2020)
• Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study
  af: Domínguez, Ángela, et al.
  Udgivet: (2017)
• Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era
  af: Izquierdo, C., et al.
  Udgivet: (2020)
• Are risk factors associated with invasive pneumococcal disease according to different serotypes?
  af: Ciruela, Pilar, et al.
  Udgivet: (2013)
• Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain
  af: Ludwig, Guillermo, et al.
  Udgivet: (2020)